Search Results
Aug 31, 2026, 06:05 ET Karmanos Now Offers FDA-Approved Daraxonrasib (Rasonque) for Metastatic Pancreatic Cancer
pancreatic cancer that will soon change how advanced disease is managed, after encouraging results from a phase III clinical trial and
More news about: Karmanos Cancer Institute
Aug 31, 2026, 01:30 ET WORQ Receives Frost & Sullivan's 2026 Malaysian Flexible Workspace Competitive Strategy Leadership Recognition for Excellence in Flexible Workspace Strategy
the Global Startup Awards 2026. A testament to its reputable status, WORQ has been graced by numerous global icons, including His Majesty King Charles III, then Prince of Wales, during his 2017 visit.As the needs of businesses evolve, WORQ has expanded its workplace solutions with a people-first
More news about: Frost & Sullivan
Aug 31, 2026, 01:30 ET WORQ Receives Frost & Sullivan's 2026 Malaysian Flexible Workspace Competitive Strategy Leadership Recognition for Excellence in Flexible Workspace Strategy
the Global Startup Awards 2026. A testament to its reputable status, WORQ has been graced by numerous global icons, including His Majesty King Charles III, then Prince of Wales, during his 2017 visit.As the needs of businesses evolve, WORQ has expanded its workplace solutions with a people-first
More news about: Frost & Sullivan
Aug 31, 2026, 01:00 ET Samsung Biologics publishes prospectus for PolyPeptide public tender offer
Maryland, U.S., Samsung Biologics holds total global manufacturing capacity of 845,000 liters. Samsung Biologics has also secured land for Bio Campus III, laying the groundwork for future capacity expansion to support next-generation therapies and emerging modalities.Samsung Biologics leverages
More news about: Samsung Biologics
Aug 30, 2026, 21:55 ET MOEA's DoIT Showcases 31 Innovative Technologies at Meet Greater South
ITRI), the Metal Industries Research & Development Centre (MIRDC), the Institute for Information Industry (III), and the Food Industry Research and Development Institute (FIRDI).
More news about: Industrial Technology Research Institute (ITRI)
Aug 30, 2026, 06:15 ET Ascletis Announces First Participant Dosed in a Global Phase III Clinical Program of Once-Daily Oral Small Molecule GLP-1 Receptor Agonist ASC30 for Chronic Weight Management
amylin (ASC30_39FDC).About the ASC30 Global Phase III Clinical ProgramThe ASC30 global Phase III clinical program consists of two pivotal, multicenter, randomized, double-blind, placebo-controlled Phase III trials, AURORA-1 (
More news about: Ascletis Pharma Inc.
Aug 30, 2026, 06:15 ET 歌禮宣布每日一次口服小分子GLP-1受體激動劑ASC30用於長期體重管理的全球III期臨床項目完成首例受試者給藥
View original content to download multimedia:https://www.prnewswire.com/apac/zh/news-releases/glp-1asc30iii-302864375.htmlSOURCE 歌禮製藥有限公司
More news about: 歌禮製藥有限公司
Aug 29, 2026, 09:12 ET EQPT Deadline: EQPT Investors with Losses in Excess of $100K Have Opportunity to Lead EquipmentShare.com Inc Securities Lawsuit
(ii) EquipmentShare had not terminated or substantially reduced a number of the transactions with entities owned or controlled by the co-founders; (iii) as a result, EquipmentShare's financial statements were materially misleading; and (iv) as a result of the foregoing, defendants' positive statements
More news about: THE ROSEN LAW FIRM, P. A.
Aug 28, 2026, 22:00 ET Cogent Communications Holdings Securities Fraud Class Action Result of Undisclosed Demand and Backlog Issues and approximately 29% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
delivery even if timely provision was possible; (iii) as a result of (i)-(ii) above, the Company had materially misrepresented demand for its optical wavelength services and the nature of its "backlog" of wavelength orders; (iv) as a result of (i)-(iii) above, the Company was not on track to achieve its
More news about: Kahn Swick & Foti, LLC
Aug 28, 2026, 22:00 ET Wix.com Ltd. Notice of September 22, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
to those offered by other companies; (ii) the Company had understated the costs associated with developing and promoting its AI product offerings; (iii) accordingly, Defendants overstated the commercial and financial benefits of Wix's AI product offerings; and (iv) as a result, Defendants' public statements
More news about: Kahn Swick & Foti, LLC
Aug 28, 2026, 22:00 ET EquipmentShare.com Inc. Notice of September 21, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
transactions; (ii) the Company had not terminated or substantially reduce a number of the transactions with entities owned or controlled by the co-founders; (iii) as a result, the Company's financial statements were materially misleading; and (iv) that, as a result of the foregoing, Defendants' positive statements
More news about: Kahn Swick & Foti, LLC
Aug 28, 2026, 19:00 ET 디지털 미러 선도기업 와이포어, 북미에서 지능형 미러 전체 라인업 공개
테크놀로지(YFORE Technology)가 오늘 조지아주 애틀랜타 인근에 새로 건설한 생산시설을 공식 가동했다. 와이포어는 이를 기념해 인테리어 다기능 미러(Multifunctional Mirror)의 글로벌 첫 공개를 필두로 실내 디지털 미러(CMS-I), 실외 사이드 미러(CMS-III), 자동 조광 미러(Auto-Dimming Mirror)를 아우르는 디지털 미러 전체 라인업을 북미 시장에 선보였다.
More news about: YFORE
Aug 28, 2026, 16:20 ET Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
safe than Defendants had led investors to believe; (ii) accordingly, ARD-101's clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.Contact Us To Participate or Learn More:
More news about: Law Offices of Howard G. Smith
Aug 28, 2026, 16:15 ET Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
including negative safety and efficacy findings in future clinical studies (notwithstanding positive findings in earlier preclinical and clinical studies); (iii) rezpegaldesleukin, NKTR-0165, NKTR-0166 and NKTR-422 are in various stages of preclinical and clinical development, the risk of failure is high and
More news about: Nektar Therapeutics
Aug 28, 2026, 15:39 ET デジタルミラーのパイオニアであるYFORE、北米でスマートミラーのフルラインナップを発表
ジョージア州スワニー、2026年8月29日 /PRNewswire/ -- 世界をリードするTier-1自動車用電子部品サプライヤーであるYFORE Technologyは、ジョージア州アトランタ近郊に新設した米国製造施設を正式に稼働させました。今回の節目を記念して、YFOREは北米全域でデジタルミラーのフルラインナップを発表しました。これには、インテリアデジタルミラー（CMS-I）、エクステリアサイドミラー（CMS-III）、オートディミングミラーが含まれており、中でも多機能ミラーの世界初公開が注目を集めました。
More news about: YFORE
Aug 28, 2026, 14:42 ET YFORE, pionnier des rétroviseurs numériques, dévoile sa gamme complète de rétroviseurs intelligents en Amérique du Nord
complète de rétroviseurs numériques en Amérique du Nord, comprenant des rétroviseurs intérieurs numériques (CMS-I), des rétroviseurs extérieurs latéraux (CMS-III) et des rétroviseurs à atténuation automatique, avec en tête d'affiche la première mondiale de son rétroviseur multifonctionnel.
More news about: YFORE
Aug 28, 2026, 14:40 ET GoDaddy Inc. (GDDY) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Company had implemented a promotional discount for dotcom domains that were likely to and did result in shorter term contracts with smaller valuations; (iii) the Company's institution of a promotional discount on one- year dotcom contracts with shorter terms was already having a material, negative impact
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Aug 28, 2026, 13:59 ET Civitas Closes $104 Million Senior Loan for 164-Unit Class A Multifamily Community in Colorado's Vail Valley
project.The Summit is Civitas' sixth rural EB-5 project in Colorado, following Civitas Aspen Fund, Civitas Aspen Fund II, Civitas Aspen Fund III, Civitas Silverthorne, and Civitas Steamboat. Those five rural projects created EB-5 investment opportunities for over 200 families.The Summit
More news about: CIVITAS CAPITAL GROUP
Aug 28, 2026, 13:52 ET UMD Smith Appoints Former BECU CRO John Stewart to Lead the Smith Enterprise Risk Consortium
expansion."Stewart's background spans enterprise risk management, credit and operational risk, market risk and interest-rate risk modeling, economic capital, and Basel III frameworks, along with corporate strategy and leadership. His experience as both a consultant and a corporate executive gives him a broad perspective
More news about: University of Maryland's Robert H. Smith School of Business
Aug 28, 2026, 13:06 ET Liberty Restoration Group Expands Midwestern Footprint with Acquisitions of ServiceMaster of Columbia & ServiceMaster Restoration Services by KRS
recapitalizations, acquisitions, growth capital, generational transitions, and buyouts. SharpVue is currently investing from SharpVue Capital Credit Fund III, L.P., an SBIC fund. For more information, please visit www.sharpvuecapital.com.About
More news about: ServiceMaster Brands
Aug 28, 2026, 12:23 ET LifeTech Scientific Corporation Announces 2026 Interim Results
non-recurring items include (i) the other losses arising from financial assets at fair value through profit or loss; (ii) the share-based payment expenses; and (iii) the transaction expenses in connection with a proposed transaction involving the conditional acquisition of equity interest in Starway Medical Technology,
More news about: LifeTech Scientific Corporation
Aug 28, 2026, 11:10 ET WIX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Wix.com Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 22, 2026 Deadline
relative to those offered by other companies; (ii) Wix had understated the costs associated with developing and promoting its AI product offerings; and (iii) accordingly, defendants overstated the commercial and financial benefits of Wix' AI product offerings.On May 21, 2025, Wix issued a press release
More news about: Robbins Geller Rudman & Dowd LLP
Aug 28, 2026, 11:05 ET 1 MONTH CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Capricor Class Action Lawsuit Before September 28, 2026 Deadline
data for Deramiocel; (ii) the FDA had not agreed to those changes before Capricor resubmitted the Deramiocel Biologics License Application ("BLA"); (iii) as a result, there was a significant risk that the FDA could conclude the clinical results did not provide substantial evidence of effectiveness of
More news about: Robbins Geller Rudman & Dowd LLP
Aug 28, 2026, 10:42 ET YFORE, pionera en espejos digitales, presenta su gama completa de espejos inteligentes en Norteamérica
Norteamérica su gama completa de retrovisores digitales, que abarca retrovisores interiores digitales (CMS-I), retrovisores laterales exteriores (CMS-III) y retrovisores con atenuación automática, encabezada por el estreno mundial de su retrovisor multifuncional.
More news about: YFORE
Aug 28, 2026, 10:34 ET SF Intra-city's Strategic Leadership Drives Performance to New Heights in 1H 2026
its full–scenario, multi–category service capabilities enabling it to maintain good cooperative relationships with a multi–layered customer base; and (iii) further enhancement of economies of scale, optimisation of resource input strategies, refined rider network operations and the application of AI technologies
More news about: SF Intra-city